Mie Hirohata

1.3k total citations
26 papers, 938 citations indexed

About

Mie Hirohata is a scholar working on Physiology, Neurology and Pharmacology. According to data from OpenAlex, Mie Hirohata has authored 26 papers receiving a total of 938 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Physiology, 14 papers in Neurology and 5 papers in Pharmacology. Recurrent topics in Mie Hirohata's work include Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Mie Hirohata is often cited by papers focused on Alzheimer's disease research and treatments (17 papers), Parkinson's Disease Mechanisms and Treatments (7 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). Mie Hirohata collaborates with scholars based in Japan, United States and Canada. Mie Hirohata's co-authors include Masahito Yamada, Kenjiro Ono, Akiyoshi Morinaga, Hironobu Naiki, Tokuhei Ikeda, Yumiko Ohhashi, Kazuhiro Hasegawa, Junichi Takasaki, Yutaka Furukawa and Yuji Yoshiike and has published in prestigious journals such as Biochemistry, Biochemical and Biophysical Research Communications and Experimental Neurology.

In The Last Decade

Mie Hirohata

26 papers receiving 918 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mie Hirohata Japan 17 495 263 233 176 132 26 938
Tokuhei Ikeda Japan 17 614 1.2× 348 1.3× 382 1.6× 116 0.7× 172 1.3× 46 1.2k
Mario Caruana Malta 11 414 0.8× 308 1.2× 306 1.3× 103 0.6× 115 0.9× 15 875
Sravan Gopalkrishnashetty Sreenivasmurthy Hong Kong 22 452 0.9× 178 0.7× 424 1.8× 227 1.3× 124 0.9× 30 1.2k
Sachin Patil United States 18 380 0.8× 125 0.5× 472 2.0× 138 0.8× 170 1.3× 43 1.3k
Benjamin Chun‐Kit Tong Hong Kong 19 466 0.9× 154 0.6× 416 1.8× 224 1.3× 187 1.4× 24 1.2k
Huan‐Lian Chen United States 16 416 0.8× 105 0.4× 471 2.0× 114 0.6× 124 0.9× 20 1.1k
Stuart Turnbull United Kingdom 12 529 1.1× 198 0.8× 369 1.6× 161 0.9× 138 1.0× 14 966
Diana F. Silva Portugal 19 465 0.9× 235 0.9× 523 2.2× 209 1.2× 150 1.1× 28 1.2k
Jenny Russ Germany 13 628 1.3× 541 2.1× 724 3.1× 130 0.7× 236 1.8× 18 1.6k
Alice Cheng United States 11 279 0.6× 110 0.4× 304 1.3× 90 0.5× 90 0.7× 14 700

Countries citing papers authored by Mie Hirohata

Since Specialization
Citations

This map shows the geographic impact of Mie Hirohata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mie Hirohata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mie Hirohata more than expected).

Fields of papers citing papers by Mie Hirohata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mie Hirohata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mie Hirohata. The network helps show where Mie Hirohata may publish in the future.

Co-authorship network of co-authors of Mie Hirohata

This figure shows the co-authorship network connecting the top 25 collaborators of Mie Hirohata. A scholar is included among the top collaborators of Mie Hirohata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mie Hirohata. Mie Hirohata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawarabayashi, Takeshi, Teruhiko Terakawa, Atsushi Takahashi, et al.. (2019). Oral Immunization with Soybean Storage Protein Containing Amyloid-β 4–10 Prevents Spatial Learning Decline. Journal of Alzheimer s Disease. 70(2). 487–503. 5 indexed citations
2.
Nakamura, Takumi, et al.. (2019). Perineuritis Successfully Treated with Early Aggressive Immunotherapy. Internal Medicine. 58(19). 2875–2878. 2 indexed citations
3.
Hirohata, Mie, Kenjiro Ono, Junichi Takasaki, et al.. (2012). Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1822(8). 1316–1324. 33 indexed citations
4.
Morinaga, Akiyoshi, Kenjiro Ono, Junichi Takasaki, et al.. (2011). Effects of sex hormones on Alzheimer's disease-associated β-amyloid oligomer formation in vitro. Experimental Neurology. 228(2). 298–302. 28 indexed citations
5.
Hirohata, Mie, Kenjiro Ono, Akiyoshi Morinaga, Tokuhei Ikeda, & Masahito Yamada. (2011). Cerebrospinal fluid from patients with multiple system atrophy promotes in vitro α-synuclein fibril formation. Neuroscience Letters. 491(1). 48–52. 11 indexed citations
6.
Hirohata, Mie, Mitsuhiro Yoshita, Chiho Ishida, et al.. (2010). Clinical features of non‐hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. European Journal of Neurology. 17(6). 823–829. 41 indexed citations
7.
Hirohata, Mie, Kenjiro Ono, Akiyoshi Morinaga, Tokuhei Ikeda, & Masahito Yamada. (2009). Anti-aggregation and fibril-destabilizing effects of sex hormones on α-synuclein fibrils in vitro. Experimental Neurology. 217(2). 434–439. 50 indexed citations
8.
Hirohata, Mie, Kenjiro Ono, & Masahito Yamada. (2008). Non-Steroidal Anti-Inflammatory Drugs as Anti-Amyloidogenic Compounds. Current Pharmaceutical Design. 14(30). 3280–3294. 21 indexed citations
9.
Ono, Kenjiro, Mie Hirohata, & Masahito Yamada. (2008). β-Synuclein Assembly as a Therapeutic Target of Parkinsons Disease and Related Disorders. Current Pharmaceutical Design. 14(30). 3247–3266. 32 indexed citations
10.
Ono, Kenjiro, Mie Hirohata, & Masahito Yamada. (2007). Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro. Journal of Neuroscience Research. 85(7). 1547–1557. 37 indexed citations
11.
Hirohata, Mie, Kenjiro Ono, Akiyoshi Morinaga, & Masahito Yamada. (2007). Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro. Neuropharmacology. 54(3). 620–627. 41 indexed citations
12.
Morinaga, Akiyoshi, Mie Hirohata, Kenjiro Ono, & Masahito Yamada. (2007). Estrogen has anti-amyloidogenic effects on Alzheimer’s β-amyloid fibrils in vitro. Biochemical and Biophysical Research Communications. 359(3). 697–702. 33 indexed citations
13.
Ono, Kenjiro, Mie Hirohata, & Masahito Yamada. (2007). Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases. Experimental Neurology. 205(2). 414–424. 32 indexed citations
14.
Hirohata, Mie, Kazuhiro Hasegawa, Yumiko Ohhashi, et al.. (2007). The Anti-Amyloidogenic Effect Is Exerted against Alzheimer's β-Amyloid Fibrils in Vitro by Preferential and Reversible Binding of Flavonoids to the Amyloid Fibril Structure. Biochemistry. 46(7). 1888–1899. 144 indexed citations
15.
Hirohata, Mie, Kenjiro Ono, Hironobu Naiki, & Masahito Yamada. (2006). P4–243: Non–steroidal anti–inflammatory drugs have anti–amyloidogenic effects for Alzheimer's beta–amyloid fibrils in vitro. Alzheimer s & Dementia. 2(3S_Part_19). 2 indexed citations
16.
Hirohata, Mie, et al.. (2005). Reversible cortical lesions in primary Sjögren's syndrome presenting with meningoencephalitis as an initial manifestation. Journal of the Neurological Sciences. 232(1-2). 111–113. 13 indexed citations
17.
Hirohata, Mie, Kenjiro Ono, Hironobu Naiki, & Masahito Yamada. (2005). Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. Neuropharmacology. 49(7). 1088–1099. 104 indexed citations
18.
Ono, Kenjiro, Mie Hirohata, & Masahito Yamada. (2005). Ferulic acid destabilizes preformed β-amyloid fibrils in vitro. Biochemical and Biophysical Research Communications. 336(2). 444–449. 150 indexed citations
19.
Yamada, Masahito, Yutaka Furukawa, & Mie Hirohata. (2003). Amyotrophic lateral sclerosis: frequent complications by cervical spondylosis. Journal of Orthopaedic Science. 8(6). 878–881. 41 indexed citations
20.
Hirohata, Mie, et al.. (1997). Follow-up study of Moya-Moya and Moya-Moya-like diseases in adults. Clinical Neurology and Neurosurgery. 99. S66–S67. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tokuhei Ikeda Breakdown of academic impact, for papers by Mario Caruana Breakdown of academic impact, for papers by Sravan Gopalkrishnashetty Sreenivasmurthy Breakdown of academic impact, for papers by Sachin Patil Breakdown of academic impact, for papers by Benjamin Chun‐Kit Tong Breakdown of academic impact, for papers by Huan‐Lian Chen Breakdown of academic impact, for papers by Stuart Turnbull Breakdown of academic impact, for papers by Diana F. Silva Breakdown of academic impact, for papers by Jenny Russ Breakdown of academic impact, for papers by Alice Cheng
Rankless by CCL
2026